TM Pharma SRL
The score of TM Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -1 % Total assets +3 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
TM Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −45,372 € | ||||
| Equity | 916,345 € | ||||
| Cash | 117,609 € | ||||
| EBITDA | 36,234 € | ||||
| Total assets | €1.68m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 16 Aug 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
TM Pharma's financial analysis
- Solvency54.5%sector median: 58.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of TM Pharma
TM Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0881.130.182
- VAT number
- BE0881130182
- Peppol
- Registered · 0208:0881130182 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 May 2006
- Registered office
- 2650 Edegem
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
TM Pharma (SRL) has been based in Edegem since 2006, active in: business and other management consultancy activities. For 2025, it reports a net loss of 45,372 € and equity of 916,345 €; its revenue is not published. Its solvency stands at 54.5%, below the median of its sector (58.9%).
Companies similar to TM Pharma
Companies in the same business, of comparable size and area, outside its group.
- Crobephar Business and other management consultancy activities Quévy · balance sheet €1.56m
- Delvaux Holding Business and other management consultancy activities Herstal · balance sheet €1.10m
- VAN Haren Management Business and other management consultancy activities Sprimont · balance sheet €2.60m
- KYKS Business and other management consultancy activities Forest · balance sheet €2.70m
- Mathis Pharma Business and other management consultancy activities Bruges · balance sheet €1.06m
- T-Oline Business and other management consultancy activities Ferrières · balance sheet 987,312 €
- Filip Gilias Rental and operating of own or leased real estate Glabbeek · balance sheet €1.03m
- Antares Invest Retail sale of pharmaceutical products Celles (lez-Tournai) · balance sheet €1.80m
Frequently asked questions about TM Pharma
What is the revenue of TM Pharma?
TM Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of TM Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0881130182 for TM Pharma, if the company is VAT-registered. Its company number (CBE) is 0881.130.182.
Where is the registered office of TM Pharma?
According to the CBE register, the registered office of TM Pharma is in 2650 Edegem.
What is the equity of TM Pharma?
At the close of the 2025 financial year, the equity of TM Pharma amounts to 916,345 €, a solvency of 54.5% of total assets.
Who manages TM Pharma?
The register lists 2 active mandates at TM Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of TM Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →